Celta Vigo have been given a tricky trip to Greece as part of their Europa League play-off tie, as they seek to win their ...

Real Madrid face an instant rematch with Benfica in the Champions League knockout stage play-offs. The Spanish giants have to navigate a two-legged play-off tie next month after losing in Portugal on ...

View post: Five Things I Liked About My Arcade's Atari Gamestation Go (and Two I Didn't) "The Studio" was renewed for season 2 before season 1 ended. Filming for season 2 begins next week, ...

GameSpot may get a commission from retail offers. Kingdom Come: Deliverance 2 developer Warhorse has revealed one feature that it cut from the RPG because it was too weird and not very fun. Speaking ...

OASIS+ is a suite of six multiple-award, indefinite-delivery/indefinite-quantity contracts with a five-year base period and a five-year option term. The contract ...

The actress talks dream costars, ensemble chemistry, and what she hopes lies ahead for her fast-talking marketing exec on Apple TV's Emmy winning comedy. After a successful first season of The Studio, ...

More antibodies take aim at seeded propagation. New data ties tangle location to deficits in specific cognitive domains. Three first-in-human studies for antibodies targeting different parts of tau ...

LAWRENCE, Kan. (KCTV) - The next phase of the University of Kansas’ renovation of David Booth Kansas Memorial Stadium and the accompanying Gateway District project is underway. Construction crews ...

Eni SpA said Tuesday the second phase of Congo LNG in the Republic of the Congo has started operations, bringing the project's capacity to three million metric tons per annum (MMtpa) of liquefied ...

Apple released the macOS Tahoe 26.2 beta 3 earlier this week and it has a couple of new features that will be of interest to AI developers. The first was actually introduced in the 26.2 beta 2 a few ...

AnaptysBio has abandoned plans to develop rosnilimab for ulcerative colitis (UC) after the PD-1 agonist flunked a phase 2 study. The San Diego-based biopharma assessed rosnilimab in the midstage study ...